Showing 2381-2390 of 2812 results for "".
- Ozempic Face: A Trade-off for Significant Weight Loss?https://modernaesthetics.com/news/ozempic-face-a-trade-off-for-significant-weight-loss/2473354/It seems like everyone is taking Ozempic/Wegovy (semaglutide, Novo Nordisk) or Mounjaro (tirzepatide, Lilly) for weight loss these days, and many are reporting a side effect dubbed “Ozempic face” by the media. Facial plastic surgeons are seeing an uptick in patients concerned that rapid we
- Study: Jeuveau “Extra-Strength” Dose Shows Lasting Resultshttps://modernaesthetics.com/news/evolus-to-present-phase-2-interim-data-from-jeuveau-extra-strength-dose-for-extended-duration-study-at-2023-imcas-world-congress/2473346/Evolus' Jeuveau Extra-Strength achieved one-point improvement on the Glabellar Lines Scale with the duration of effect lasting 26 weeks, representing a prolonged 6-month performance, the Company reports. The extra-strength glabellar line study is a multicenter, double
- Juvederm Volux XC for Jaw Definition Is Herehttps://modernaesthetics.com/news/juvederm-volux-xc-for-jaw-definition-is-here/2473344/Allergan Aesthetics' Juvéderm Volux XC is now available at aesthetic practices nationwide. The filler is approved for patients older than 21 with moderate to severe loss of jawline definition. "With 40% of aesthetically-aware consumers considering tre
- Endo Pulls Qwo from Markethttps://modernaesthetics.com/news/endo-pulls-qwo-from-market/2473339/Endo International plc is ceasing the production and sale of Endo Aesthetics' Qwo (collagenase clostridium histolyticum-aaes) in light of market concerns about the extent and variability of bruising following initial treatment as well as the potential for prolonged skin discoloratio
- Merz Aesthetics Adds SaltFacial to Portfolio of Productshttps://modernaesthetics.com/news/merz-aesthetics-adds-saltfacial-to-portfolio-of-products/2473332/Merz Aesthetics and SaltMED are extending their commercial agreement adding The SaltFacial by SaltMED to the portfolio of products offered by Merz Aesthetics. The SaltFacial is a skin rejuvenation system that targets the texture, tone ,and color of skin. The S
- Upcoming Webinar: How Updates on USP 797 Will Affect Your IV Hydration Therapy Businesshttps://modernaesthetics.com/news/upcoming-webinar-how-updates-on-usp-797-will-affect-your-iv-hydration-therapy-business/2473327/The American IV Association is hosting a webinar, How the New Updates on USP 797 Can and Will Affect Your IV Hydration Therapy Business, on Wednesday, November 16 from 12-1pm EST.
- Hydrafacial and Glytone Team Up to Launch New Boosterhttps://modernaesthetics.com/news/hydrafacial-and-glytone-team-up-to-launch-new-booster-1/2473323/The Beauty Health Company’s Hydrafacial is rolling out a new exfoliating booster co-created with Glytone. The Glytone AHA Resurfacing Cellular Booster leverages a unique combination of three alpha hydroxy acids (AHAs) that may help improve the appearance of skin surface and textur
- New from Alastin: Meet A-LUMINATE BRIGHTENING SERUMhttps://modernaesthetics.com/news/new-from-alastin-meet-a-luminate-brightening-serum/2473316/Galderma’s ALASTIN Skincare is rolling out A-LUMINATE BRIGHTENING SERUM to help reduce the appearance of surface pigmentation without any harsh, irritating ingredients. A-LUMINATE BRIGHTENING SERUM contains a multifaceted blend of peptides, antioxidants, and targeted in
- Hugel Resubmits BLA for Botulaxhttps://modernaesthetics.com/news/hugel-resubmits-bla-for-botulax/2473314/Hugel resubmitted the BLA for its botulinum toxin called Botulax for smoothing glabellar lines to the U.S. FDA. Hugel had received a Complete Response Letter (CRL) from the U.S. FDA last March after submitting the BLA for Botulax (50 and 100 units) to advance into the U.S. market i
- ASDS News: Patients Love Galderma's Investigational Liquid Botulinum Toxinhttps://modernaesthetics.com/news/asds-news-patients-love-galdermas-investigational-liquid-botulinum-toxin/2473312/Galderma's investigational ready-to-use liquid botulinum toxin RelabotulinumtoxinA scored high patient satisfaction and psychological well-being ratings for the treatment of glabellar lines and lateral canthal lines in addition to previously reported safety and efficacy, according to pre